At the beginning of the COVID-19 pandemic, we rapidly launched the ES96 automated sample processing system for high-throughput sample partitioning and the flexible throughput pipetting workstation to support PCR reaction setup (A1, N96) to assist in large-scale personnel screening for the virus. In the COVID-19 genome sequencing workflow, we provides flexible automated library preparation solutions for customers with different throughput requirements.
The second and third-generation sequencing technologies have been widely used in the fields of reproduction, oncology, and infection. However, the library preparation process for these technologies is complex, time-consuming, and requires highly skilled operators. Based on the sequencing and library preparation requirements of different fields, NAYO Biotechnology has developed flexible library preparation solutions that cover different throughputs and are compatible with second and third-generation sequencing platforms.
Drug development involves target discovery and validation, screening and optimization of lead compounds or antibodies, pre-clinical research, and clinical trials. Researchers typically need to conduct tedious screening experiments to identify lead compounds/antibodies and advance the drug development process. Based on the liquid handling process involved in the discovery of small and large molecule drugs, Novogene offers flexible liquid handling equipment with different throughputs to help improve screening efficiency。
Molecular breeding technology can significantly reduce the time required for improving animal and plant species, and the advancement of genomic technology has made high-throughput genotyping of larger populations possible, thereby accelerating the breeding process. Nayo Biotechnology provides high-throughput solutions for sample quality control and genotyping, helping to improve the efficiency of molecular breeding。
Animal disease prevention and control are of great significance in reducing epidemic losses, ensuring the quality of animal products, and reducing zoonotic diseases. For priority animal diseases in national animal epidemic prevention such as African swine fever, foot-and-mouth disease, highly pathogenic avian influenza, and brucellosis, Nayo Biotechnology provides high-throughput solutions such as agglutination test, ELISA, and qPCR to assist in the efficient implementation of epidemic prevention work.